Hervé Jacquier

Dr. Hervé Jacquier


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
EFEric Farfour
Eric Farfour
Laurent DORTETLaurent DORTET
Laurent DORTET
TGThomas Guillard
Thomas Guillard
NCNicolas Chatelain
Nicolas Chatelain
APAgathe Poisson
Agathe Poisson
OGon behalf of the GMC Study Group
on behalf of the GMC Study Group
In the context of increasing antimicrobial resistance in Enterobacterales, the management of these UTIs has become challenging. We retrospectively assess the prevalence of antimicrobial resistance in Enterobacterales isolates recovered from urinary tract samples in France, between 1 September 2017, to 31 August 2018. Twenty-six French clinical laboratories provided the susceptibility of 134,162 Enterobacterales isolates to 17 antimicrobials. The most frequent species were E. coli (72.0%), Klebsiella pneumoniae (9.7%), Proteus mirabilis (5.8%), and Enterobacter cloacae complex (2.9%). The overall rate of ESBL-producing Enterobacterales was 6.7%, and ranged from 1.0% in P. mirabilis to 19.5% in K. pneumoniae, and from 3.1% in outpatients to 13.6% in long-term care facilities. Overall, 4.1%, 9.3% and 10.5% of the isolates were resistant to cefoxitin, temocillin and pivmecillinam. Cotrimoxazole was the less active compound with 23.4% resistance. Conversely, 4.4%, 12.9%, and 14.3% of the strains were resistant to fosfomycin, nitrofurantoin, and ciprofloxacin. However, less than 1% of E. coli was resistant to fosfomycin and nitrofurantoin. We identified several trends in antibiotics resistances among Enterobacterales isolates recovered from the urinary tract samples in France. Carbapenem-sparing drugs, such as temocillin, mecillinam, fosfomycin, cefoxitin, and nitrofurantoin, remained highly active, including towards ESBL-E.

1 November 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CCClaire de Curraize
Claire de Curraize
SKSylvain Kumanski
Sylvain Kumanski
MMMaïté Micaëlo
Maïté Micaëlo
NFNelly Fournet
Nelly Fournet
GRGuy La Ruche
Guy La Ruche
BBBéatrice Bercot
Béatrice Bercot
Two extended-spectrum cephalosporin-resistant Neisseria gonorrhoeae isolates were discovered among 6,340 (0.03%) French isolates between 2010 and 2014. One isolate corresponded to the F89 multidrug-resistant N. gonorrhoeae isolate harboring a penA mosaic; whole-genome sequencing highlighted an additional R251H substitution in the ftsX gene recently involved in cephalosporin resistance. The other, ceftriaxone-resistant isolate (MIC, 0.25 mg/liter) harbored the PBP2 pattern XXXVI plus a P551S substitution and belonged to sequence type ST1579 (multilocus sequence typing [MLST]).

1 August 2012 in Microbial Drug Resistance
Verified
Journal Article
Closed access
HJHervé Jacquier
Hervé Jacquier
AMAlban Le Monnier
Alban Le Monnier
ECEtienne Carbonnelle
Etienne Carbonnelle
SCStephane Corvec
Stephane Corvec
MIMarina Illiaquer
Marina Illiaquer
VGVincent Cattoir on Behalf of the GMC Study Group
Vincent Cattoir on Behalf of the GMC Study Group
In this prospective multicentric study, we assessed the in vitro antimicrobial activity of carbapenems (imipenem, meropenem, and doripenem), tigecycline, and colistin against 166 unusual nonfermenting Gram-negative bacilli (NF-GNB) clinical isolates collected from nine French hospitals during a 6-month period (from December 1, 2008, to May 31, 2009). All NF-GNB isolates were included, except those phenotypically identified as Pseudomonas aeruginosa or Acinetobacter baumannii . Minimal inhibitory concentrations (MICs) of antimicrobial agents were determined by using the E -test technique. The following microorganisms were identified: Stenotrophomonas maltophilia ( n =72), Pseudomonas spp. ( n =30), Achromobacter xylosoxidans ( n =25), Acinetobacter spp. ( n =18), Burkholderia cepacia complex ( n =9), Alcaligenes faecalis ( n =7), and Delftia spp. ( n =5). All isolates of Acinetobacter spp., A. faecalis , and Delftia spp. were susceptible to the three carbapenems. Imipenem exhibited the lowest MICs against Pseudomonas spp., and meropenem, as compared with imipenem and doripenem, displayed an interesting antimicrobial activity against A. xylosoxidans and B. cepacia complex isolates. Conversely, no carbapenem exhibited any activity against S. maltophilia . Except for S. maltophilia isolates, tigecycline and colistin exhibited higher MICs than carbapenems, but covered most of the microorganisms tested in this study. To our knowledge, no prior study has compared antimicrobial activity of these five antibiotics, often considered as “last-resort” treatment options for resistant Gram-negative infections, against unusual NF-GNB clinical isolates. Further studies should be carried out to assess the potential clinical use of these antibiotics for the treatment of infections due to these microorganisms.

1 December 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
HJHervé Jacquier
Hervé Jacquier
VFVincent FIHMAN
Vincent FIHMAN
RARishma Amarsy
Rishma Amarsy
EVEric Vicaut
Eric Vicaut
VBValérie Bousson
Valérie Bousson
ALAmanda Lopes
Amanda Lopes
The microbiological diagnosis of bone and joint infections (BJI) currently relies on cultures, and the relevance of molecular methods is still debated. The aim of this study was to determine whether polymerase chain reaction (PCR) could improve the etiological diagnosis of BJI. A prospective study was conducted during a 4-year period at Lariboisiere University Hospital (Paris, France), including patients with suspicion of infectious spondylodiscitis, septic arthritis, prosthetic joint infections, and respective noninfected groups. Clinical and radiological data were collected at inclusion and during follow-up. All samples were analyzed by conventional cultures and 16S ribosomal deoxyribonucleic acid (rDNA) gene (16S-PCR). Specific cultures and PCR targeting Mycobacterium tuberculosis were also performed for spondylodiscitis samples. Case records were subsequently analyzed by an independent expert committee to confirm or invalidate the suspicion of infection and definitively classify the patients in a case or control group. The sensitivity of the combination of culture and PCR was compared with culture alone. After expert committee analysis, 105 cases of BJI cases and 111 control patients were analyzed. The most common pathogens of BJI were staphylococci (30%), M tuberculosis (19%), and streptococci (14%). Adding PCR enhanced the sensitivity compared with culture alone (1) for the diagnosis of M tuberculosis spondylodiscitis (64.4% vs 42.2%; P < .01) and (2) for nonstaphylococci BJI (81.6% vs 71.3%; P < .01). It is interesting to note that 16S-PCR could detect BJI due to uncommon bacteria such as Mycoplasma and fastidious bacteria. Our study showed the benefit of 16S-PCR and PCR targeting M tuberculosis as add-on tests in cases of suspected BJI.

20 June 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MDMarie Dulin
Marie Dulin
SCSylvie Chevret
Sylvie Chevret
MSMaud Salmona
Maud Salmona
HJHervé Jacquier
Hervé Jacquier
BBBéatrice Bercot
Béatrice Bercot
AMAnne-Lise Munier
Anne-Lise Munier
Background: Varicella zoster virus (VZV) can reactivate and cause meningitis, but few studies have distinguished it from meningoencephalitis regarding treatment recommendations. The objective of this study was to assess the outcomes of a large series of patients with VZV meningitis according to their therapeutic management. Methods: We conducted a bicentric retrospective cohort study, in Paris, France, including all adult patients with a cerebrospinal fluid sample positive for VZV by polymerase chain reaction between April 2014 and June 2022. We distinguished meningitis from encephalitis according to the International Encephalitis Consortium criteria. Unfavorable outcome was defined as mortality or functional sequelae defined by a loss of 2 points on the modified Rankin Scale. Results: We included 123 patients with meningitis. Among them, 14% received no antivirals, while 20% were treated with oral valacyclovir alone, 41% with a short course of intravenous (IV) acyclovir before switch to valacyclovir, and 25% with a long course of IV acyclovir. Outcomes were favorable regardless of antiviral regimen. In multivariate analysis, only age, underlying immunosuppression, and cranial radiculitis appear to be predictive factors for longer IV therapy, based on the Akaike information criterion. Conclusions: In this study, patients with VZV meningitis had a good outcome, with no evidence of any impact of the treatment strategy. However, further studies are needed to support the possibility of milder treatment in immunocompetent patients, avoiding cost and side effects of IV acyclovir.

1 December 2021 in Journal of Infection
Verified
Journal Article
Closed access
GPGauthier Péan de Ponfilly
Gauthier Péan de Ponfilly
ACAnthony CHAUVIN
Anthony CHAUVIN
MSMaud Salmona
Maud Salmona
HBHanaa Benmansour
Hanaa Benmansour
BBBéatrice Bercot
Béatrice Bercot
HJHervé Jacquier
Hervé Jacquier